North America Respiratory Care Devices Industry Size

The report "North America Respiratory Care Device Market by Product (PAP Device, Ventilator, Humidifier, Oxygen Concentrator, Spirometer, Peak Flow Meter, Mask), Disease Indication (Asthma, Infectious Disease), End User (Hospital, Homecare Setting)-Forecast to 2031", is projected to grow from USD 10.53 billion in 2026 and to reach USD 15.31 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.

Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "North America Respiratory Care Device Market by Product (PAP Device, Ventilator, Humidifier, Oxygen Concentrator, Spirometer, Peak Flow Meter, Mask), Disease Indication (Asthma, Infectious Disease), End User (Hospital, Homecare Setting)-Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-respiratory-care-devices-market-222311730.html

The North America respiratory care devices market is growing significantly due to an increase in the number of people suffering from chronic respiratory diseases such as COPD, asthma, and sleep apnea, as well as population aging, which makes the elderly more susceptible to respiratory diseases. Advanced healthcare facilities, the large amount of money spent on healthcare, and strong healthcare reimbursement systems are some factors that help the quick adoption of advanced respiratory solutions both in hospitals and at home. In addition, people's growing preference for home-based and noninvasive treatments, along with better understanding of early diagnosis and long-term disease management, is driving market growth. Also, constant technological innovations, such as smart ventilators, connected CPAP systems, and oxygen therapy devices with improved features, are making patients more comfortable and treatments more effective, thus supporting continuous market growth in the whole region.

Therapeutic respiratory care devices accounted for the largest share by product in the North America respiratory care devices market in 2025.

Within the product segment, therapeutic respiratory care devices currently lead the market in North America due to their important role in treating various chronic and acute respiratory diseases, including COPD, asthma, sleep apnea, and respiratory failure. A variety of products, such as ventilators, CPAP and BiPAP machines, oxygen therapy devices, and nebulizers, are widely used not just in hospitals but also in long-term care centers and home care settings; therefore, these are the main drivers of a continuously stable demand. The enormous number of patients who require continuous respiratory therapy, along with favorable reimbursement policies and an increasing trend toward home-based treatment options, has further consolidated the dominance of therapeutic devices over diagnostic and monitoring solutions across the region.

The hospitals segment accounted for the largest share of the North America respiratory care devices market by end user in 2025.

Respiratory care devices have been predominantly used in hospitals, especially in North America. Hospitals are the primary settings where patients with acute and severe respiratory diseases, such as respiratory failure, pneumonia, COPD exacerbations, and complications from asthma and sleep apnea, are first diagnosed and treated. It is common for hospitals to know the faces of severely ill patients who need advanced respiratory support, such as ventilators, oxygen therapy systems, and noninvasive ventilation devices, especially in intensive care units and emergency departments. In addition, continuous patient monitoring, the presence of skilled healthcare professionals, and well-established procurement systems are among the factors that enable hospitals to install and retain various respiratory care devices, helping them maintain their market leadership.

In 2025, the US accounted for the largest share of the North America respiratory care devices market.

The US leads the pack with the largest share of the North American respiratory care devices market, primarily due to its large patient population with chronic respiratory diseases such as COPD, asthma, and sleep apnea, as well as a high number of hospital admissions for respiratory conditions. In addition, the U.S. has a well-developed healthcare infrastructure and vast ICU capacity, and it has witnessed strong adoption of advanced medical technologies not only in hospitals but also in home care. Moreover, the market benefits from favorable reimbursement policies, high healthcare spending, and the presence of major, very strong respiratory device manufacturers. On top of this, public education about respiratory health, the widespread use of home therapy devices, and continuous product innovations have helped the U.S. maintain its first position in the regional respiratory care devices market.

Key Market Players

The key players in the North America respiratory care devices are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), Masimo (US), and other players.

Don’t miss out on business opportunities in North America Respiratory Care Device Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/